Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4R7X

Crystal structure of N-lobe of human ARRDC3(1-180)

Summary for 4R7X
Entry DOI10.2210/pdb4r7x/pdb
Related4R7V
DescriptorArrestin domain-containing protein 3, PHOSPHATE ION (3 entities in total)
Functional Keywordsarrestin fold, gpcr downregulation, beat 2 adrenergic receptor, protein binding
Biological sourceHomo sapiens (human)
Cellular locationCytoplasm : Q96B67
Total number of polymer chains2
Total formula weight42827.36
Authors
Qi, S.,Hurley, J. (deposition date: 2014-08-28, release date: 2014-10-01, Last modification date: 2024-02-28)
Primary citationQi, S.,O'Hayre, M.,Gutkind, J.S.,Hurley, J.H.
Insights into beta 2-adrenergic receptor binding from structures of the N-terminal lobe of ARRDC3.
Protein Sci., 23:1708-1716, 2014
Cited by
PubMed Abstract: ARRDC3 is one of six known human α-arrestins, and has been implicated in the downregulation of the β2-adrenergic receptor (β2AR). ARRDC3 consists of a two-lobed arrestin fold and a C-terminal tail containing two PPYX motifs. In the current model for receptor downregulation by ARRDC3, the arrestin fold portion is thought to bind the receptor, while the PPXY motifs recruit ubiquitin ligases of the NEDD4 family. Here we report the crystal structures of the N-terminal lobe of human ARRDC3 in two conformations, at 1.73 and 2.8 Å resolution, respectively. The structures reveal a large electropositive region that is capable of binding phosphate ions of crystallization. Residues within the basic patch were shown to be important for binding to β2AR, similar to the situation with β-arrestins. This highlights potential parallels in receptor recognition between α- and β-arrestins.
PubMed: 25220262
DOI: 10.1002/pro.2549
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.61 Å)
Structure validation

245663

数据于2025-12-03公开中

PDB statisticsPDBj update infoContact PDBjnumon